Michael Kenison

Corporate Officer/Principal bij PROTO LABS, INC.

Vermogen: 692 210 $ op 31-05-2024

Process Industries

Commercial Services

Actieve functies van Michael Kenison

Bedrijven	Functie	Begin	Einde
PROTO LABS, INC.	Corporate Officer/Principal	01-06-2021	-

Bedrijven	Functie	Begin	Einde
Cardiac Science, Inc. Cardiac Science, Inc. Miscellaneous Commercial ServicesCommercial Services Cardiac has developed RHYTHMx ECD, technology that continuously monitors a patient's heart rhythm and provided defibrillation to help the organ keep a steady beat. Cardiac Science has used the technology to develop an external cardiac defibrillator, the Powerheart, which is used in hospitals. The firm also sold patient monitors and emergency defibrillators, and has developed a small portable defibrillator that can be used by patients in the hospital or at home. Cardiac Science markets its products in more than 50 countries worldwide.	Corporate Officer/Principal	-	-

Internationaal

Verenigde Staten

Operationeel

Corporate Officer/Principal

Sectoraal

Process Industries	2
Commercial Services	2

Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Beursgenoteerde bedrijven	1
PROTO LABS, INC.	Process Industries

Bedrijven in privébezit	1
Cardiac Science, Inc. Cardiac Science, Inc. Miscellaneous Commercial ServicesCommercial Services Cardiac has developed RHYTHMx ECD, technology that continuously monitors a patient's heart rhythm and provided defibrillation to help the organ keep a steady beat. Cardiac Science has used the technology to develop an external cardiac defibrillator, the Powerheart, which is used in hospitals. The firm also sold patient monitors and emergency defibrillators, and has developed a small portable defibrillator that can be used by patients in the hospital or at home. Cardiac Science markets its products in more than 50 countries worldwide.	Commercial Services

Bedrijven in privébezit

Commercial Services